| Business

Become a contributor

Bookmark Econotimes

| Business

Bain Capital Secures RBI Approval to Acquire Up to 41.7% Stake in Manappuram Finance

Federal Court Fines Mobil Oil Australia A$16 Million for Misleading Fuel Claims

Paramount Skydance Appoints Rene Augustine as SVP of Global Public Policy Amid Warner Bros Takeover Battle

India AI Impact Summit 2026: Global Tech CEOs Join World Leaders in New Delhi

Treasury Wine Estates Profit Falls 46% as China and U.S. Inventory Reset Weighs on Earnings

Freedom Finance and Binance Join Forces in Digital Assets

Anderson Cooper to Exit CBS News’ 60 Minutes After Nearly 20 Years

Starboard Value Targets Tripadvisor Board Overhaul Amid Stock Slump

Anduril Industries Seeks $8 Billion Funding at $60 Billion Valuation

OpenAI Hires OpenClaw Creator Peter Steinberger to Advance Next-Generation AI Agents

AstroTurf Expands Footprint at Colorado as Buffaloes Complete Second Installation in 12 Months

Macquarie-Led Consortium to Acquire Qube Holdings in A$11.7 Billion Deal

Luxury Stocks Face Volatility as AI Market Swings and Hedge Fund Bets Rattle LVMH and Kering

Bank of America CEO Brian Moynihan’s 2025 Compensation Rises 17% to $41 Million Amid Strong Profit Growth

Anduril Eyes $60 Billion Valuation in New Funding Round to Expand Defense Manufacturing and Autonomous Fighter Jet Development

Thomas Pritzker to Step Down as Hyatt Executive Chairman After Epstein Ties Acknowledged

Warner Bros. Discovery Weighs Renewed Sale Talks With Paramount Skydance Amid Netflix Deal Review

©Econometrics LLC . All Rights Reserved.

Teligent, Inc. to Hold Conference Call for First Quarter 2018 Results

Thursday, April 26, 2018 6:15 PM UTC

BUENA, N.J., April 26, 2018 -- Teligent, Inc. (NASDAQ:TLGT), a New Jersey-based specialty generic pharmaceutical company, announced the Company will hold a conference call at 4:30pm ET on Monday, May 7, 2018 to discuss the 1^st quarter 2018 financial results and business update.

The Company invites you to listen to the call by dialing (866) 393-8366. International participants should call (409) 350-3154. Participants should ask to join the Teligent, Inc. call.

This call is available via webcast and can be accessed in the Investor Relations Section of Teligent, Inc.'s website at www.teligent.com.

About Teligent, Inc.
Teligent is a specialty generic pharmaceutical company. Our mission is to be a leading player in the specialty generic prescription drug market. Learn more on our website www.teligent.com.

Contact:
Damian Finio
Teligent, Inc.
(856) 336-9117
www.teligent.com

Editor's Picks

Breathing through your nose when you exercise may make your runs easier

Entrepreneurs are facing a mental health crisis — here's how to help them

Are fish oil supplements as healthy as we think? And is eating fish better?

Will AI kill our creativity? It could – if we don’t start to value and protect the traits that make us human

Does AI have a right to free speech? Only if it supports our right to free thought

How can I lower my cholesterol? Do supplements work? How about psyllium or probiotics?

Why we need to set limits on sperm donation

Aging with a healthy brain: How lifestyle changes could help prevent up to 40% of dementia cases

Seven techniques to avoid weight regain, approved by experts

Market Data

Ireland’s Data Protection Commission Launches GDPR Investigation Into X’s AI Chatbot Grok

India AI Impact Summit 2026: Global Tech CEOs Join World Leaders in New Delhi

Ukraine-Russia Peace Talks in Geneva Focus on Land Disputes and Donetsk Control

Australia Refuses Repatriation of Citizens Held in Syrian ISIS Camp

Oil Prices Steady as Iran Strait of Hormuz Drills Heighten Supply Concerns Ahead of U.S. Nuclear Talks

Trump Signals Indirect Role in U.S.-Iran Nuclear Talks as Tensions Rise

Israel Approves West Bank Land Registration Plan, Palestinians Warn of ‘De-Facto Annexation’

U.S. Stock Futures Steady as Investors Await Fed Minutes and Key Economic Data

Dollar Holds Firm as Fed Rate Cut Expectations and Global Data Drive Currency Markets

EconoTimes

Disclaimer: EconoTimes provides references and links to selected blogs and other sources of economic and market information as an educational service to its clients and prospects and does not endorse the opinions or recommendations of the blogs or other sources of information. Clients and prospects are advised to carefully consider the opinions and analysis offered in the blogs or other information sources in the context of the client or prospect's individual analysis and decision making. None of the blogs or other sources of information is to be considered as constituting a track record. Past performance is no guarantee of future results and EconoTimes specifically advises clients and prospects to carefully review all claims and representations made by advisors, bloggers, money managers and system vendors before investing any funds or opening an account with any Brokerage. Any news, opinions, research, data, or other information contained within this website is provided as general market commentary and does not constitute investment or trading advice. EconoTimes expressly disclaims any liability for any lost principal or profits without limitation which may arise directly or indirectly from the use of or reliance on such information. As with all such advisory services, past results are never a guarantee of future results.

Teligent, Inc. to Hold Conference Call for First Quarter 2018 Results

Editor's Picks

Welcome to EconoTimes